Andrew D. Leavitt

5.1k total citations · 2 hit papers
71 papers, 3.2k citations indexed

About

Andrew D. Leavitt is a scholar working on Hematology, Molecular Biology and Surgery. According to data from OpenAlex, Andrew D. Leavitt has authored 71 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 16 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Andrew D. Leavitt's work include Platelet Disorders and Treatments (20 papers), Hemophilia Treatment and Research (13 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Andrew D. Leavitt is often cited by papers focused on Platelet Disorders and Treatments (20 papers), Hemophilia Treatment and Research (13 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Andrew D. Leavitt collaborates with scholars based in United States, United Kingdom and France. Andrew D. Leavitt's co-authors include Harold Varmus, Lily Shiue, Sanford J. Shattil, Emmanuelle Passegué, Berthold Göttgens, Joshua M. Stuart, Yoon-A Kang, Damien Reynaud, Eric M. Pietras and Fernando J. Calero‐Nieto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Andrew D. Leavitt

69 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

2021 489 citations Gary H. Lyman, Marc Carrier et al. Blood Advances profile →
Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions

2015 455 citations Andrew D. Leavitt, Berthold Göttgens et al. profile →

Peers

Countries citing papers authored by Andrew D. Leavitt

Since Specialization

Citations

This map shows the geographic impact of Andrew D. Leavitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Leavitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Leavitt more than expected).

Fields of papers citing papers by Andrew D. Leavitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Leavitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Leavitt. The network helps show where Andrew D. Leavitt may publish in the future.

Co-authorship network of co-authors of Andrew D. Leavitt

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Leavitt. A scholar is included among the top collaborators of Andrew D. Leavitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Leavitt. Andrew D. Leavitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neural ensembles that encode nocifensive mechanical and heat pain in mouse spinal cord 2025 ·Nature Neuroscience ·Mingdong Zhang, Jussi Kupari, Jie Su, (unknown), Yizhou Hu, Laura Calvo-Enrique, Dmitry Usoskin, (unknown), (unknown), Katharina Henriksson, Andrew D. Leavitt, Hanns Ulrich Zeilhofer, Tomas Hökfelt, Malin C. Lagerström, Patrik Ernfors	1
2	Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1 2025 ·Hämostaseologie ·Andrew D. Leavitt, Johnny Mahlangu, (unknown), Emily Symington, Doris Quon, Adam Giermasz, Gili Kenet, Gillian Lowe, Nigel S. Key, (unknown), Steven W. Pipe, (unknown), (unknown), Robert Klamroth, Jody M. Mason, Hérvè Chambost, Flora Peyvandi, Haiyan Yu, Tara M. Robinson, Margareth C. Ozelo	0
3	Efficacy and Safety of Giroctocogene Fitelparvovec in Adults with Moderately Severe to Severe Hemophilia Α: Primary Analysis Results from the Phase 3 ΑFFINE Gene Therapy Trial 2024 ·Blood ·Andrew D. Leavitt, Kaan Kavaklı, Laurent Frenzel, Bülent Antmen, Margareth C. Ozelo, Davide Matino, (unknown), Barbara A. Konkle, Steven W. Pipe, Jerome Teitel, Li‐Jung Tseng, Annie Fang, (unknown), (unknown), Jeremy Rupon, Klaus Pietzner, Jasmine Healy, (unknown), Francesca Biondo, (unknown)	2
4	Screening Characteristics of Hemoglobin and Mean Corpuscular Volume for Detection of Iron Deficiency in Pregnancy 2024 ·Obstetrics and Gynecology ·Hui Chao, Travis Zack, Andrew D. Leavitt	3
5	Observational cohort study of long‐term outcomes of liver transplantation in haemophilia 2023 ·Haemophilia ·Margaret V. Ragni, J. B. Callis, (unknown), (unknown), (unknown), (unknown), Jonathan P. Schwartz, Kenneth D. Friedman, Peter A. Kouides, Philip Kuriakose, Andrew D. Leavitt, Ming Y. Lim, (unknown), Michael Recht, (unknown)	1
6	Efficacy and safety of valoctocogene roxaparvovec gene transfer for severe hemophilia A: results from the GENEr8-1 three-year analysis 2023 ·Hämostaseologie ·Johnny Mahlangu, (unknown), Susan Shapiro, (unknown), Margareth C. Ozelo, Gili Kenet, Flora Peyvandi, (unknown), (unknown), Amy L. Dunn, Jody M. Mason, Doris Quon, Andrew D. Leavitt, Johannes Oldenburg, Hérvè Chambost, Mark T. Reding, (unknown), (unknown), Tara M. Robinson, S. W. PIPE	1
7	American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer breakdown → 2021 ·Blood Advances ·Gary H. Lyman, Marc Carrier, Cihan Ay, Marcello Di Nisio, Lisa K. Hicks, Alok A. Khorana, Andrew D. Leavitt, Agnes Lee, Fergus Macbeth, Rebecca L. Morgan, Simon Noble, (unknown), David D. Stenehjem, Wojtek Wiercioch, Lara A Kahale, Pablo Alonso‐Coello	489
8	SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP 2021 ·Blood ·Eun‐Ju Lee, Marina Beltrami Moreira, Hanny Al‐Samkari, Adam Cuker, (unknown), Terry Gernsheimer, (unknown), Craig M. Kessler, Caroline Kruse, Andrew D. Leavitt, Alfred Ian Lee, Howard A. Liebman, Adrian C. Newland, (unknown), Michael D. Tarantino, Jecko Thachil, David J. Kuter, Douglas B. Cines, James B. Bussel	47
9	Updated Results of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (PF-07055480/SB-525) Gene Therapy in Adults with Severe Hemophilia a 2021 ·Blood ·Nathan Visweshwar, Thomas J. Harrington, Andrew D. Leavitt, Barbara A. Konkle, Adam Giermasz, Kimo C. Stine, Jeremy Rupon, G. Russo, Li‐Jung Tseng, (unknown), (unknown), (unknown), (unknown), Didier Rouy, (unknown), Annie Fang, Steven Arkin	16
10	Marked Hyperbilirubinemia—Silent No More! 2020 ·The American Journal of Medicine ·Vanessa E. Kennedy, Andrew D. Leavitt, (unknown)	0
11	Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors 2019 ·American Journal of Hematology ·Rebecca Karp Leaf, (unknown), Deepa Rangachari, James W. Mier, (unknown), George Ansstas, Theodora Anagnostou, Leyre Zubiri, Zofia Piotrowska, Thein Hlaing Oo, David Iberri, Mark Yarchoan, April K.S. Salama, Douglas B. Johnson, Andrew D. Leavitt, Osama E. Rahma, Kerry L. Reynolds, David E. Leaf	49
12	Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes 2018 ·Cancer Research ·Wen Bu, Zhenyu Liu, Weiyu Jiang, Chandandeep Nagi, Shixia Huang, Dean P. Edwards, Eunji Jo, Qianxing Mo, Chad J. Creighton, Susan G. Hilsenbeck, Andrew D. Leavitt, Michael T. Lewis, Stephen T.C. Wong, Yi Li	31
13	Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery 2016 ·Thrombosis and Haemostasis ·Tyler W. Buckner, Andrew D. Leavitt, Margaret V. Ragni, Christine L. Kempton, M. Elaine Eyster, Adam Cuker, Steven R. Lentz, Jonathan M. Ducore, Cindy Leissinger, Mike Wang, Nigel S. Key	28
14	Capturing and Manipulating Activated Neuronal Ensembles with CANE Delineates a Hypothalamic Social-Fear Circuit 2016 ·Neuron ·Katsuyasu Sakurai, Shengli Zhao, Jun Takatoh, Erica Rodriguez, Jinghao Lu, Andrew D. Leavitt, Min Fu, Bao-Xia Han, Fan Wang	126
15	Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer 2011 ·Oncogene ·Wen Bu, Jun Chen, (unknown), Shixia Huang, Chad J. Creighton, Jian Huang, Gary C. Chamness, Susan G. Hilsenbeck, Dennis R. Roop, Andrew D. Leavitt, Yi Li	43
16	Homologous Recombination in Human Embryonic Stem Cells: A Tool for Advancing Cell Therapy and Understanding and Treating Human Disease 2011 ·Clinical and Translational Science ·Andrew D. Leavitt, (unknown)	17
17	Subpopulations of Human Embryonic Stem Cells With Distinct Tissue-Specific Fates Can Be Selected From Pluripotent Cultures 2009 ·Stem Cells and Development ·Frank W. King, Carissa Ritner, Walter Liszewski, Helen Kwan, (unknown), Andrew D. Leavitt, Harold S. Bernstein	34
18	Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function 2006 ·Journal of Thrombosis and Haemostasis ·Meenakshi Gaur, Tamihiro Kamata, S. Wang, Barry Moran, Sanford J. Shattil, Andrew D. Leavitt	100
19	Manipulation of Mouse Hematopoietic Progenitors by Specific Retroviral Infection 2003 ·Journal of Biological Chemistry ·George J. Murphy, Berthold Göttgens, Alexandros Vegiopoulos, María J. Sánchez, Andrew D. Leavitt, Steve P. Watson, Anthony R. Green, Jon Frampton	11
20	Circulating red cells usually remain of host origin after bone marrow transplantation for severe combined immunodeficiency 1996 ·Transfusion ·(unknown), Morton J. Cowan, Andrew D. Leavitt	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact